Valuation: Orum Therapeutics, Inc.

Market Cap 350B 264M 236M 218M 198M 370M 25.13B 376M 2.63B 1.04B 13.14B 991M 970M 41.61B P/E 2024 *
-
P/E 2025 -59.5x
Enterprise Value 243B 183M 164M 152M 137M 257M 17.45B 261M 1.83B 722M 9.13B 688M 674M 28.89B EV / Sales 2024 *
-
EV / Sales 2025 103,580x
Free-Float
83.68%
Yield 2024 *
-
Yield 2025 -
1 day-0.92%
1 week-6.23%
Current month-27.27%
1 month-35.56%
3 months-64.59%
6 months-80.89%
Current year-86.58%
1 week 15,900
Extreme 15900
17,560
1 month 15,690
Extreme 15690
26,000
Current year 15,690
Extreme 15690
146,600
1 year 15,690
Extreme 15690
146,600
3 years 15,690
Extreme 15690
146,600
5 years 15,690
Extreme 15690
146,600
10 years 15,690
Extreme 15690
146,600
Manager TitleAgeSince
Chief Executive Officer 52 17/08/2016
Director of Finance/CFO 44 23/10/2023
Chief Tech/Sci/R&D Officer - 05/01/2026
Director TitleAgeSince
Director/Board Member 52 17/08/2016
Director/Board Member 44 23/10/2023
Director/Board Member 55 01/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
21/2/25 Free

Founder

3,388,000 -
21/2/25 Free

Chief Financial Officer

10,000 -
21/2/25 Free

Director

60,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-6.23%-52.62% - 264M
+0.88%-0.34%+40.64%+73.05% 65.28B
-0.23%-0.18%+9.60%+77.16% 54.57B
-0.35%+1.15%+9.26%+100.95% 53.59B
-2.06%+2.90%+24.07%+48.36% 45.03B
-1.79%+0.19%+19.32%+123.62% 42.17B
-1.65%+0.96%+237.56%+823.66% 39.42B
-2.26%-4.14%+15.38%+45.53% 32.71B
-2.70%-10.77%+19.80%-6.47% 24.01B
+0.30%+14.34%+59.09%+48.23% 26.5B
Average -1.07%+2.06%+38.21%+148.23% 38.35B
Weighted average by Cap. -0.88%+2.27%+45.54%+148.35%

Financials

2024 2025
Net sales 20.91B 15.75M 14.09M 13.03M 11.8M 22.09M 1.5B 22.45M 157M 62.04M 784M 59.13M 57.87M 2.48B 23.56M 17.76K 15.88K 14.69K 13.3K 24.9K 1.69M 25.3K 177K 69.93K 884K 66.65K 65.22K 2.8M
Net income -5.74B -4.33M -3.87M -3.58M -3.24M -6.06M -412M -6.16M -43.06M -17.03M -215M -16.24M -15.89M -682M -41.97B -31.63M -28.28M -26.17M -23.69M -44.34M -3.01B -45.07M -315M -125M -1.57B -119M -116M -4.98B
Net Debt -90.47B -68.18M -60.96M -56.4M -51.07M -95.58M -6.49B -97.14M -679M -268M -3.39B -256M -250M -10.74B -107B -80.71M -72.17M -66.77M -60.46M -113M -7.68B -115M -804M -318M -4.02B -303M -296M -12.72B
Projected Income Statement - Annual - Orum Therapeutics, Inc.
Logo Orum Therapeutics, Inc.
Orum Therapeutics Inc is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company is principally engaged in the research and development of new biopharmaceuticals for cancer and immune diseases based on its platforms.
Employees
24
Date Price Change Volume
26/10/26 ₩16,110.00 -0.92% 91,099
23/10/26 ₩16,260.00 -4.01% 139,538
22/10/26 ₩16,940.00 -1.51% 190,274
21/10/26 ₩17,200.00 +5.91% 193,085
20/10/26 ₩16,240.00 -5.47% 129,384
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A475830 Stock